A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 38,654 shares of CDMO stock, worth $476,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,654
Previous 39,479 2.09%
Holding current value
$476,603
Previous $281,000 56.23%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.7 - $12.45 $5,527 - $10,271
-825 Reduced 2.09%
38,654 $439,000
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $250,296 - $366,365
39,479 New
39,479 $281,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $767M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.